Download PDF
Aktuelle Dermatologie 2001; 27(10): 295-305
DOI: 10.1055/s-2001-18674
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Tinea capitis - ein aktueller Überblick

Tinea capitis - A Topical SurveyBernadette  Manz1 , U.-F.  Haustein1 , P.  Nenoff1
  • 1Klinik und Poliklinik für Hautkrankheiten der Universität Leipzig (Direktor: Prof. Dr. U.-F. Haustein)
Further Information

Publication History

Publication Date:
30 November 2001 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Klinisches Bild, Nativpräparat sowie mykologische Kultur sind die diagnostischen Eckpfeiler der Tinea capitis. Griseofulvin ist in Deutschland für die systemische Therapie der Kopfpilzerkrankung bei Kindern das bislang einzig uneingeschränkt zugelassene Medikament. Die neuen Ergosterolbiosyntheseinhibitoren Terbinafin, Itraconazol und Fluconazol sind zwar in kontrollierten Studien für andere Indikationen geprüft und zur systemischen antimykotischen Behandlung von Erwachsenen zugelassen, jedoch noch nicht für Kinder mit Tinea capitis. Bisher fehlen umfangreichere doppelblinde und randomisierte Vergleichsstudien mit Griseofulvin und den neuen Ergosterolbiosyntheseinhibitoren bei Tinea capitis. Fast alle größeren offenen Studien konnten jedoch zeigen, dass die neuen Antimykotika Terbinafin, Itraconazol und Fluconazol dem Griseofulvin durch kürzere Therapiezeiten und höhere Heilungsraten überlegen sind.

Abstract

Clinical picture, potassium hydroxide preparation and fungal culture are the principal diagnostic tools of tinea capitis. In Germany, griseofulvin is the only approved antifungal agent for the treatment of tinea capitis in children. The modern ergosterole biosynthesis inhibitors (terbinafine, itraconazole, and fluconazole) are namely tested and allowed for antifungal therapy in adults. They are not yet admitted for the treatment of children with tinea capitis. Thus, far few randomized double blind controlled studies concerning the effectiveness of these agents for the systemic therapy of tinea capitis have been published. Almost all open studies showed that the modern antifungals terbinafine, itraconazole, and fluconazole are superior to griseofulvin because of shorter duration of therapy and higher rates of cure.

Literatur

  • 1 Abdel-Rahman S M, Nahata M C, Powell D A. Response to initial griseofulvin therapy in pediatric patients with tinea capitis.  Ann Pharmacother. 1997;  31 406-410
    PubMedGoogle Scholar
  • 2 Abdel-Rahman S M, Powell D A, Nahata M C. Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis.  J Am Acad Dermatol. 1998;  38 443-446
    PubMedGoogle Scholar
  • 3 Aste N, Pau M, Biggio P. Tinea capitis in children in the district of Cagliari, Italy.  Mycoses. 1997;  40 231-233
    PubMedGoogle Scholar
  • 4 Beller M, Gessner B D. An outbreak of tinea corporis gladiatorum on a high school wrestling team.  J Am Acad Dermatol. 1994;  31 197-201
    PubMedGoogle Scholar
  • 5 Blank H, Roth F J. The treatment of dermatomycoses with orally administered griseofulvin.  Arch Dermatol. 1959;  79 259-266
    PubMedGoogle Scholar
  • 6 Bruckbauer H R, Hofmann H. Systemic antifungal treatment of children with terbinafine.  Dermatology. 1997;  195 145-136
    PubMedGoogle Scholar
  • 7 Cohen B A, Schmidt C. Tinea gladiatorum.  N Engl J Med. 1992;  327 820
    PubMedGoogle Scholar
  • 8 Degreef H. Itraconazole in the treatment of tinea capitis.  Cutis. 1996;  58 90-93
    PubMedGoogle Scholar
  • 9 Dragos V, Lunder M. Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children.  Pediatr Dermatol. 1997;  14 46-48
    PubMedGoogle Scholar
  • 10 Elewski B. Tinea capitis.  Dermatol Clin. 1996;  14 23-31
    CrossrefPubMedGoogle Scholar
  • 11 Elewski B E, Hay R J. International summit on cutaneous antifungal therapy, focus on tinea capitis, Boston, Massachusetts, November 11 - 13, 1994.  Ped Dermatol. 1996;  13 69-77
    PubMedGoogle Scholar
  • 12 Elewski B E. Tinea capitis: itraconazole in Trichophyton tonsurans infection.  J Am Acad Dermatol. 1994;  31 65-67
    PubMedGoogle Scholar
  • 13 Elewski B E. Treatment of tinea capitis with itraconazole.  Int J Dermatol. 1997;  36 539-541
    PubMedGoogle Scholar
  • 14 Emmon C W. Dermatophytes: natural groupings based on the form of spores and accessory organs.  Arch Dermatol Syphilol. 1934;  30 337-362
    PubMedGoogle Scholar
  • 15 Flammia M P, Vannini E M. Tinea capitis in the Florence area between 1985 and 1993.  Mycoses. 1995;  38 325-328
    PubMedGoogle Scholar
  • 16 Gentles J C. Experimental ringworm in guinea pigs: oral treatment with griseofulvin.  Nature. 1958;  182 476-477
    CrossrefPubMedGoogle Scholar
  • 17 Gianni C, Betti R, Perotta E, Crosti C. Tinea capitis in adults.  Mycoses. 1995;  38 329-331
    PubMedGoogle Scholar
  • 18 Greer D L. Treatment of tinea capitis with itraconazole.  J Am Acad Dermatol. 1996;  35 637-638
    CrossrefPubMedGoogle Scholar
  • 19 Gupta A K, Adam P, Hofstader S L. Itraconazole oral solution for the treatment of onychomycosis.  Pediatr Dermatol. 1998;  15 472-474
    CrossrefPubMedGoogle Scholar
  • 20 Gupta A K, Adam P. Terbinafine pulse therapy is effective in tinea capitis.  Pediatr Dermatol. 1998;  15 56-58
    CrossrefPubMedGoogle Scholar
  • 21 Gupta A K, Alexis M E, Raboobee N, Hofstader S L, Lynde C W, Adam P, Summerbell R C, Doncker P D. Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: an open multicentre study.  Br J Dermatol. 1997;  137 251-254
    CrossrefPubMedGoogle Scholar
  • 22 Gupta A K, Hofstader S L, Summerbell R C, Solomon R, Adam P, Alexis M, Raboobee N, De Doncker P. Treatment of tinea capitis with itraconazole capsule pulse therapy.  J Am Acad Dermatol. 1998;  39 216-219
    PubMedGoogle Scholar
  • 23 Gupta A K, Nolting S, de Prost Y, Delescluse J, Degreef H, Theissen U, Wallace R, Marynissen G, De Doncker P. The use of itraconazole to treat cutaneous fungal infections in children.  Dermatology. 1999;  199 248-252
    CrossrefPubMedGoogle Scholar
  • 24 Gupta A K, Sauder D N, Shear N H. Antifungal agents: an overview. Part I.  J Am Acad Dermatol. 1994;  30 677-698
    PubMedGoogle Scholar
  • 25 Gupta A K, Shear N H, Sauder D N. New Antifungal Agents.  Curr Opin Dermatol. 1993;  2 200-206
    PubMedGoogle Scholar
  • 26 Gupta A K, Solomon R S, Adam P. Itraconazole oral solution for the treatment of tinea capitis.  Br J Dermatol. 1998;  139 104-106
    CrossrefPubMedGoogle Scholar
  • 27 Hackendorf J A, Donald G F, Linn H W. Favus.  Australas J Dermatol. 1965;  8 22-30
    PubMedGoogle Scholar
  • 28 Hamm H, Schwinn A, Brautigam M, Weidinger G. Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group.  Br J Dermatol. 1999;  140 480-482
    CrossrefPubMedGoogle Scholar
  • 29 Haroon T S, Hussain I, Aman S, Jahangir M, Kazmi A H, Sami A R, Nagi A H, Alvi K H, Iybal N, Khan K A, Aziz R. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis.  Br J Dermatol. 1996;  135 86-88
    CrossrefPubMedGoogle Scholar
  • 30 Haroon T S, Hussain I, Mahmood A, Nagi A H, Ahmad I, Zahid M. An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis.  Br J Dermatol. 1992;  26 47-50
    PubMedGoogle Scholar
  • 31 Hay R J. Epidemiological survey on tinea capitis in Europe.  Mycology Newsletter. 1998;  1 13-14
    PubMedGoogle Scholar
  • 32 De Hoog G S, Guarro J, Gené J, Figueras M J. T. interdigitale. . In: De Hoog GS, Guarro J, Gené J, Figueras MJ (Eds) Atlas of clinical fungi. Rovira i Virgili, Spain; Universitad 2000
    Google Scholar
  • 33 Howard R, Frieden I J. Tinea capitis: new perspectives on an old disease.  Semin Dermatol. 1995;  14 2-8
    PubMedGoogle Scholar
  • 34 Hradil E, Hersle K, Nordin P, Faergemann J. An epidemic of tinea corporis caused by Trichophyton tonsurans among wrestlers in Sweden.  Acta Derm Venereol. 1995;  33 305-306
    PubMedGoogle Scholar
  • 35 Jahangir M, Hussain I, Hasan M, Haroon T S. A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis.  Br J Dermatol. 1998;  139 672-674
    CrossrefPubMedGoogle Scholar
  • 36 Korstanje M J, Staats C G. Tinea capitis in Northwestern Europe 1963-1993: etiologic agents and their changing prevalence.  Int J Dermatol. 1994;  33 548-549
    PubMedGoogle Scholar
  • 37 Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis.  J Am Acad Dermatol. 1997;  37 272-273
    PubMedGoogle Scholar
  • 38 Leeming J G, Elliott T S. The emergence of Trichophyton tonsurans tinea capitis in Birmingham, U.K.  Br J Dermatol. 1995;  133 929-931
    CrossrefPubMedGoogle Scholar
  • 39 Legendre R, Escola-Macre J. Itraconazole in the treatment of Tinea capitis.  J Am Acad Dermatol. 1990;  23 559-560
    PubMedGoogle Scholar
  • 40 Lewis S M, Lewis B G. Nosocomial transmission of Trichophyton tonsurans tinea corporis in a rehabilitation hospital.  Infect Control Hosp Epidemiol. 1997;  18 322-325
    PubMedGoogle Scholar
  • 41 Lopez-Gomez S, Del Palacio A, Van Cutsem J, Soledad Cuetara M, Iglesias L, Rodriguez-Noriega A. Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children.  Int J Dermatol. 1994;  33 743-747
    PubMedGoogle Scholar
  • 42 Maibach H I, Kligman A M. Short-term treatment of onycomycosis with grisefulvin.  Arch Dermatol. 1969;  81 733-734
    PubMedGoogle Scholar
  • 43 Martinez-Roig A, Torres-Rodriguez J M, Bartlett-Coma A. Double blind study of ketoconazole and griseofulvin in dermatophytoses.  Pediatr Infect Dis J. 1988;  7 37-40
    PubMedGoogle Scholar
  • 44 Mercurio M G, Silverman R A, Elewski B E. Tinea capitis: fluconazole in Trichophyton tonsurans infection.  Pediatr Dermatol. 1998;  15 229-232
    CrossrefPubMedGoogle Scholar
  • 45 Mills C M, Philpot C M. Tinea capitis in south Wales - observations in change of causative fungi.  Clin Exp Dermatol. 1994;  19 473-475
    PubMedGoogle Scholar
  • 46 Möhrenschläger M, Abeck D. Tinea capitis im Kindesalter.  Akt Dermatol. 2000;  26 9-13
    PubMedGoogle Scholar
  • 47 Montero-Gei F. Fluconazole in the treatment of tinea capitis.  Int J Dermatol. 1998;  37 870-871
    CrossrefPubMedGoogle Scholar
  • 48 Nenoff P, Gebauer S, Lipski S, Haustein U F. Tinea capitis et faciei gladiatorum durch Trichophyton tonsurans Malmsten.  Zeitschr H+G. 1998;  4 217-222
    PubMedGoogle Scholar
  • 49 Nenoff P, Gebauer S, Rytter M, Haustein U F. Tinea capitis et corporis durch Microsporum canis.  Derm Prakt Dermatologie. 1997;  3 302-308
    PubMedGoogle Scholar
  • 50 Nenoff P, Haustein U F. Tinea corporis due to Trichophyton tonsurans Malmsten - report of a patient from Zaire.  Mycoses. 1997;  40 127-129
    PubMedGoogle Scholar
  • 51 Nenoff P, Haustein U F. In vitro susceptibility testing of Pityrosporum ovale against antifungal antiseborrheic and antisporiatic agents.  J Acad Dermatol Venerol. 1994;  3 331-333
    PubMedGoogle Scholar
  • 52 Oxford A E, Raistrick H, Simonart P. Studies in the biochemistry of microorganisms: griseofulvin, C17H17O6Cl, a metabolic product of Penicillium griseofulvum.  Biochem J. 1939;  33 240-248
    PubMedGoogle Scholar
  • 53 Pusey W A. The History of dermatology. Springfield, IL; Charles C. Thomas 1933
    Google Scholar
  • 54 Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.  N Z Med J. 1998;  27 55-57
    PubMedGoogle Scholar
  • 55 Rieth H. Epidemiologie der Mykosen in Deutschland und Wandel im Erregerspektrum.  Münch Med Wschr. 1976;  118 69-76
    PubMedGoogle Scholar
  • 56 Rippon J W. Forty four years of dermatophytes in a Chicago clinic (1944-1988).  Mycopathologia. 1993;  119 25-28
    PubMedGoogle Scholar
  • 57 Rosenthal T. Perspectives in ringworm of the scalp.  Arch Dermatol. 1960;  82 851-856
    PubMedGoogle Scholar
  • 58 Russell B, Frain-Bell W, Stevenson C J. Chronic ringworm infection of the skin and nails treated with griseofulvin.  Lancet. 1960;  1 1140-1147
    PubMedGoogle Scholar
  • 59 Sabouraud R. Les teignes. Paris; Masson 1910
    Google Scholar
  • 60 Solomon B A, Collins R, Sharma R, Silverberg N, Jain A R, Sedgh J, Laude T A. Fluconazole for the treatment of tinea capitis in children.  J Am Acad Dermatol. 1997;  37 274-275
    PubMedGoogle Scholar
  • 61 Solomons B. Disorders of the hair and their treatment before the 18th century.  Br J Dermatol. 1966;  78 113-120
    PubMedGoogle Scholar
  • 62 Stiller M J, Klein W P, Dorman I R, Rosenthal S. Tinea corporis gladiatorum: an epidemic of Trichophyton tonsurans in student wrestlers.  J Am Acad Dermatol. 1992;  27 632-633
    PubMedGoogle Scholar
  • 63 Takwale A, Agarwal S, Homes S, Berth-Jones J. Tinea capitis in two elderly women: transmission at the hairdresser.  Br J Dermatol. 2001;  144 898-900
    CrossrefPubMedGoogle Scholar
  • 64 Tanz R R, Stagl S, Esterly N B. Comparison of ketoconazole and griseofulvin for treatment of tinea capitis in childhood: a preliminary study.  Pediatr Emerg Care. 1985;  1 16-18
    PubMedGoogle Scholar
  • 65 Tietz H J, Ulbricht H M, Sterry W. Tinea capitis in Deutschland - Ergebnisse einer epidemiologischen Analyse.  Zeitschr H+G. 1999;  74 683-688
    PubMedGoogle Scholar
  • 66 Tietz H J, Kunzelmann V, Schönian G. Changes in the fungal spectrum of dermatomycoses.  Mycoses. 1995;  38 33-39
    PubMedGoogle Scholar
  • 67 Vargo K, Cohen B A. Prevalence of undetected tinea capitis in household members of children with disease.  Pediatrics. 1993;  92 155-157
    PubMedGoogle Scholar
  • 68 Vanbreugsghem R. Trichophyton soudanense in and outside Africa.  Br J Dermatol. 1968;  80 140-148
    PubMedGoogle Scholar
  • 69 Weitzman I. Variation in Microsporum gypseum. I. A genetic study of pleomorphism.  Sabouraudia. 1964;  3 195-204
    PubMedGoogle Scholar
  • 70 Williams D I, Marten R H, Sarkany I. Oral treatment of ringworm with griseofulvin.  Lancet. 1958;  21 212-213
    PubMedGoogle Scholar
  • 71 Williams J V, Honig P J, McGinley K J, Leyden J J. Semiquantitative study of tinea capitis and the asymptomatic carrier state in inner-city school children.  Pediatrics. 1995;  96 265-267
    PubMedGoogle Scholar
  • 72 Wood B, Rademaker M. Nosocomial Trichophyton tonsurans in a long stay ward.  N Z Med J. 1997;  110 277-278
    PubMedGoogle Scholar

Bernadette Manz

Klinik und Poliklinik für Haut- und Geschlechtskrankheiten · Universitätsklinikum Leipzig

Stephanstraße 11 · 04103 Leipzig

      >